1. Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9

   • Charles A. German
   • Michael D. Shapiro

   Leading Article 28 November 2019 Pages: 1 - 9

   

2. The Therapeutic Potential of Nanobodies

   • Ivana Jovčevska
   • Serge Muyldermans

   Review Article Open access 04 November 2019 Pages: 11 - 26

   

3. Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents

   • Vibeke Strand
   • Joao Gonçalves
   • John D. Isaacs

   Review Article Open access 13 November 2019 Pages: 27 - 37

   

4. Current Considerations on Characterization of Immune Response to Multi-Domain Biotherapeutics

   • Boris Gorovits
   • Kun Peng
   • Arno Kromminga

   Review Article 22 October 2019 Pages: 39 - 54

5. In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study

   • Ylenia Ingrasciotta
   • Valeria Belleudi
   • On behalf of the Italian Biosimilars Network (I-BioNetwork)

   Original Research Article 08 October 2019 Pages: 55 - 64

   

6. Comparative Physicochemical and Biological Characterisation of the Similar Biological Medicinal Product Teriparatide and Its Reference Medicinal Product

   • Piroska Kovács
   • Tamás Schäfer
   • Zoltán Urbányi

   Original Research Article Open access 08 October 2019 Pages: 65 - 75

   

7. Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar

   • Thomas F. Lerch
   • Penelope Sharpe
   • Hugh D. Conlon

   Original Research Article Open access 24 October 2019 Pages: 77 - 87

   

8. Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry

   • Hyoun-Ah Kim
   • Eunyoung Lee
   • Kichul Shin

   Original Research Article Open access 16 November 2019 Pages: 89 - 98

   

9. Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study

   • Yaerim Kim
   • Su-Kil Park
   • Kyubok Jin

   Original Research Article 20 November 2019 Pages: 99 - 110